Masparen

Galantamine, the active ingredient in Masparen, is an acetylcholinesterase inhibitor presented as an oral dosage form for oral use. It is indicated for the symptomatic treatment of mild to moderate Alzheimer’s disease in adult patients, helping to improve cognition and daily functioning.

GNH USA supplies Masparen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution, with reliable logistics and dedicated customer service.

Galantamine is used within the Alzheimer’s disease therapeutic pathway to address cognitive decline.

Mild Alzheimer’s disease: helps improve memory and attention Moderate Alzheimer’s disease: supports daily functioning and cognition Alzheimer’s disease‑related cognitive decline: may stabilize symptoms

Galantamine may cause adverse reactions; they are grouped by frequency.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools occurring early in therapy. - Dizziness: transient light‑headedness, especially on standing. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe liver injury: elevated transaminases or hepatitis. - Cardiac arrhythmia: bradycardia or heart block. - Seizures: rare convulsive episodes. - Hallucinations: visual or auditory disturbances. - Anaphylaxis: acute allergic reaction with rash, swelling, or breathing difficulty. - Hepatotoxicity: signs of liver dysfunction requiring monitoring.

When prescribing Galantamine, consider the following precautions.

Renal impairment: monitor renal function and adjust therapy if needed. Hepatic disease: use with caution; assess liver enzymes regularly. Cardiac conduction disorders: avoid in patients with symptomatic bradyarrhythmias. Concurrent anticholinergic drugs: may diminish therapeutic benefit. Pregnancy and lactation: safety not established; weigh risks and benefits. Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Galantamine can interact with other medicines; notable interactions include:

Major Interactions (Avoid): - Anticholinergic agents: may reduce Galantamine efficacy. - Beta‑blockers: increased risk of bradycardia. - CYP2D6 inhibitors (e.g., quinidine): elevate Galantamine plasma levels.

Moderate Interactions (Monitor Closely): - Other cholinesterase inhibitors (e.g., donepezil): additive cholinergic effects. - NSAIDs: potential for gastrointestinal irritation. - SSRIs or other antidepressants: monitor for enhanced nausea or dizziness.